Latest stories on AQST
Aquestive Therapeutics: Rating Downgrade Despite Probability Of Anaphylm Approval
Seeking Alpha33 · bearishanalyst
AQST Q1 2026 Earnings Call Transcript
Yahoo Top50 · neutralearnings
Aquestive Therapeutics, Inc. (AQST) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Aquestive Therapeutics Q1 Earnings Call Highlights
Yahoo Finance58 · neutralearnings
Aquestive Therapeutics GAAP EPS of -$0.07 beats by $0.07, revenue of $14.4M beats by $3.5M
Seeking Alpha61 · neutralearnings